These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
507 related items for PubMed ID: 29065834
1. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A). Khan MN, Haggag YA, Lane ME, McCarron PA, Tambuwala MM. Curr Drug Deliv; 2018 Feb 14; 15(2):286-295. PubMed ID: 29065834 [Abstract] [Full Text] [Related]
8. A comparison between PLGA-PEG and NIPAAm-MAA nanocarriers in curcumin delivery for hTERT silencing in lung cancer cell line. Roointan A, Sharifi-Rad M, Badrzadeh F, Sharifi-Rad J. Cell Mol Biol (Noisy-le-grand); 2016 Aug 29; 62(9):51-6. PubMed ID: 27585262 [Abstract] [Full Text] [Related]
10. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery. Yoon IS, Park JH, Kang HJ, Choe JH, Goh MS, Kim DD, Cho HJ. Int J Pharm; 2015 Jul 05; 488(1-2):70-7. PubMed ID: 25900098 [Abstract] [Full Text] [Related]
11. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells). Meena R, Kumar S, Kumar R, Gaharwar US, Rajamani P. Biomed Pharmacother; 2017 Oct 05; 94():944-954. PubMed ID: 28810532 [Abstract] [Full Text] [Related]
12. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier. Nair KL, Thulasidasan AK, Deepa G, Anto RJ, Kumar GS. Int J Pharm; 2012 Apr 04; 425(1-2):44-52. PubMed ID: 22266528 [Abstract] [Full Text] [Related]
15. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer. Mukerjee A, Ranjan AP, Vishwanatha JK. J Biomed Nanotechnol; 2016 Jul 04; 12(7):1374-92. PubMed ID: 29336533 [Abstract] [Full Text] [Related]
16. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells. Punfa W, Yodkeeree S, Pitchakarn P, Ampasavate C, Limtrakul P. Acta Pharmacol Sin; 2012 Jun 04; 33(6):823-31. PubMed ID: 22580738 [Abstract] [Full Text] [Related]
17. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Thamake SI, Raut SL, Gryczynski Z, Ranjan AP, Vishwanatha JK. Biomaterials; 2012 Oct 04; 33(29):7164-73. PubMed ID: 22795543 [Abstract] [Full Text] [Related]
18. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo. Klippstein R, Wang JT, El-Gogary RI, Bai J, Mustafa F, Rubio N, Bansal S, Al-Jamal WT, Al-Jamal KT. Small; 2015 Sep 04; 11(36):4704-22. PubMed ID: 26140363 [Abstract] [Full Text] [Related]
19. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms. Ye MX, Zhao YL, Li Y, Miao Q, Li ZK, Ren XL, Song LQ, Yin H, Zhang J. Phytomedicine; 2012 Jun 15; 19(8-9):779-87. PubMed ID: 22483553 [Abstract] [Full Text] [Related]
20. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells. Maiolino S, Russo A, Pagliara V, Conte C, Ungaro F, Russo G, Quaglia F. J Nanobiotechnology; 2015 Apr 03; 13():29. PubMed ID: 25888948 [Abstract] [Full Text] [Related] Page: [Next] [New Search]